Inovio制药公司的主要证券面临91天的锁闭, Inovio Pharmaceuticals' key securities face a 91-day lock-up ending Oct. 1, 2025, restricting sales by insiders.

Inovio制药公司的某些证券,包括搜查令、限制库存股和C系列首选股票,须遵守2025年10月1日截止的锁闭协议。 Certain securities of Inovio Pharmaceuticals, including warrants, restricted stock units, and Series C preferred stock, are subject to a lock-up agreement ending October 1, 2025. 从2025年7月2日开始的91天限制禁止公司、经理和董事出售、质押或转让这些股份或相关证券,但特定例外除外。 The 91-day restriction, beginning July 2, 2025, prohibits the company, executives, and directors from selling, pledging, or transferring these shares or related securities, except under specific exceptions. 报价代表可以提前放弃锁定,并在招股说明书补充日后第90天交易结束时自动终止. The lock-up may be waived early by the offering representative and automatically terminates at the close of trading on the 90th day after the prospectus supplement’s date.